News | February 20, 2024
Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
These re-agent and diagnostic test kits come with 99.7% accuracy
The company recently received CEP certificate approval for Losartan Potassium by EDQM
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Subscribe To Our Newsletter & Stay Updated
